Maxis AI launches MaxisAI Holarchy, the first Verticalized Context Layer for life sciences.Learn More →

    Maxis AI logo

    Article

    Articles & Perspectives

    Short-form analysis and opinion pieces shaping how regulated R&D teams adopt agentic AI.

    AI-powered risk-based monitoring dashboard with predictive analytics, risk indicators, and clinical trial oversight visualization

    Article

    The Advantages of Artificial Intelligence for Risk-Based Monitoring in Clinical Trials

    Learn how AI and machine learning can strengthen risk-based quality management by identifying patterns, anomalies, and emerging risks across clinical trial data—helping sponsors move toward more proactive trial oversight.

    June 26, 2024•Article
    Read Article

    Featured

    Featured Articles

    Forbes feature with Moulik Shah, Founder & CEO of Maxis AI, on combating AI bias with diverse training data, human oversight, and AI explainability

    Article

    3 Ways AI Is Reshaping Business — And How You Should Prepare for the Future

    In Forbes, Moulik Shah shares how AI is reshaping business — and why combating AI bias takes diverse training data, ongoing human oversight, and explainability.

    March 27, 2025Forbes
    Read on Forbes